Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
capicua transcriptional repressor | 0.523 | 0.692 | 1.00 |
|
disease | 0.330 | None | 1.000 | 3 | 0 | 2013 | 2015 | ||||||||
|
X-box binding protein 1 | 0.477 | 0.846 | 3.2E-02 |
|
disease | 0.330 | None | 1.000 | 3 | 0 | 2011 | 2020 | ||||||||
|
MYB proto-oncogene, transcription factor | 0.490 | 0.692 | 0.82 |
|
disease | 0.320 | None | 1.000 | 4 | 0 | 2012 | 2017 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.320 | None | 1.000 | 3 | 0 | 2001 | 2011 | ||||||||
|
high mobility group nucleosome binding domain 5 | 0.650 | 0.423 | 0.31 |
|
disease | 0.320 | None | 1.000 | 3 | 0 | 2011 | 2017 | ||||||||
|
protein phosphatase, Mg2+/Mn2+ dependent 1D | 0.513 | 0.808 | 2.2E-11 |
|
disease | 0.320 | None | 1.000 | 3 | 0 | 2012 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2C | 0.527 | 0.654 | 0.40 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2003 | 2013 | ||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2011 | 2017 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 1997 | 2018 | ||||||||
|
mutS homolog 2 | 0.406 | 0.808 | 0.90 |
|
disease | 0.320 | None | 0.500 | 2 | 1 | 2002 | 2014 | ||||||||
|
ATPase Na+/K+ transporting subunit beta 2 | 0.705 | 0.308 | 7.4E-02 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2003 | 2006 | ||||||||
|
phosphoinositide-3-kinase regulatory subunit 1 | 0.477 | 0.885 | 1.00 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2017 | 2019 | ||||||||
|
far upstream element binding protein 1 | 0.610 | 0.615 | 1.00 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2012 | 2014 | ||||||||
|
ferritin heavy chain 1 | 0.559 | 0.731 | 0.14 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2011 | 2018 | ||||||||
|
neurotrophic receptor tyrosine kinase 3 | 0.522 | 0.692 | 1.00 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2014 | 2014 | ||||||||
|
H3 clustered histone 2 | 0.653 | 0.423 | 1.5E-05 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2012 | 2016 | ||||||||
|
chloride voltage-gated channel 2 | 0.626 | 0.462 | 5.5E-12 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
deleted in malignant brain tumors 1 | 0.533 | 0.654 | 4.5E-63 |
|
disease | 0.310 | None | 1.000 | 1 | 1 | 2002 | 2002 | ||||||||
|
apolipoprotein D | 0.584 | 0.577 | 5.4E-04 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
PMS1 homolog 2, mismatch repair system component | 0.484 | 0.808 | 4.5E-27 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
ATR serine/threonine kinase | 0.456 | 0.923 | 3.5E-09 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
disease | 0.300 | None | 1.000 | 53 | 0 | 1997 | 2020 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
disease | 0.300 | None | 0.950 | 20 | 1 | 1994 | 2019 | ||||||||
|
cathepsin B | 0.457 | 0.846 | 5.9E-11 |
|
disease | 0.300 | None | 1.000 | 19 | 0 | 1994 | 2014 | ||||||||
|
gap junction protein alpha 1 | 0.393 | 0.885 | 0.16 |
|
disease | 0.300 | None | 1.000 | 19 | 0 | 1998 | 2019 |